Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Cairo University, Cairo, Egypt.
Department of Clinical Pathology, National Cancer Institute, Cairo University, Cairo, Egypt.
Asian Pac J Cancer Prev. 2023 Sep 1;24(9):3269-3274. doi: 10.31557/APJCP.2023.24.9.3269.
Osteosarcoma is considered the most common primary malignant tumor that develops from the primary osteoblasts. MiRNAs are small non-coding RNAs that play a key role in tumorigenesis. The aim of this study was to detect the possible relationship between expression levels of miRNA-34a and levels of Signal transducer and activator of transcription 3 (STAT3) and interleukin-6 receptor (IL-6R) in osteosarcoma and the possible role of this relationship in development of metastases in these patients.
A total of thirty-six (36) bone samples were included in the study. They were divided into 3 groups: Group (I): Twelve normal bone samples as control group. Group (II): Twelve patients with non-metastatic osteosarcoma. Group (III): Twelve patients with metastatic osteosarcoma. MiRNA-34a expression levels were estimated using qRT-PCR. STAT3 and IL-6R levels were measured by ELISA.
Expression level of miRNA-34a was downregulated in osteosarcoma groups compared to control group. STAT3 and IL-6R levels were upregulated in osteosarcoma groups compared to control group. This difference in expression levels was found to be more significant in the metastatic group than the non-metastatic one (P<0.001 each). There was a significant positive correlation between STAT3 and IL-6R (r=0.868, P<0.001), and a significant inverse correlation between IL6 and miRNA-34a (r=-0.993, P<0.001).
miRNA-34a, STAT3 and IL-6R feedback loop could be a potential target for treatment of osteosarcoma and can be used as prognostic indicator for this disease.
骨肉瘤被认为是最常见的原发性恶性肿瘤,它起源于原发性成骨细胞。miRNA 是一种小的非编码 RNA,在肿瘤发生中起关键作用。本研究旨在检测 miRNA-34a 表达水平与信号转导和转录激活因子 3(STAT3)和白细胞介素 6 受体(IL-6R)在骨肉瘤中的水平之间的可能关系,以及这种关系在这些患者转移发展中的可能作用。
共有 36 例(36 例)骨标本纳入本研究。它们被分为 3 组:组(I):12 例正常骨标本作为对照组。组(II):12 例非转移性骨肉瘤患者。组(III):12 例转移性骨肉瘤患者。采用 qRT-PCR 法测定 miRNA-34a 表达水平。采用 ELISA 法测定 STAT3 和 IL-6R 水平。
骨肉瘤组 miRNA-34a 的表达水平低于对照组。STAT3 和 IL-6R 水平在骨肉瘤组中高于对照组。在转移性组中,这种表达水平的差异比非转移性组更为显著(均 P<0.001)。STAT3 和 IL-6R 之间存在显著的正相关(r=0.868,P<0.001),而 IL-6 和 miRNA-34a 之间存在显著的负相关(r=-0.993,P<0.001)。
miRNA-34a、STAT3 和 IL-6R 反馈环可能是骨肉瘤治疗的潜在靶点,并可作为该疾病的预后指标。